SAFE or priced round? How the two fundraising routes differ for UK founders

What a SAFE actually is

A SAFE (Simple Agreement for Future Equity) was created by the US accelerator Y Combinator as a quick, cheap way for early-stage companies to take investment without agreeing a valuation there and then. The investor hands over cash now; in exchange they get the right to shares later, usually when the company does a proper priced funding round, is sold, or winds up. No interest, no maturity date, no valuation negotiation up front. It became popular because it lets founders close a cheque in days rather than months.

Why the UK doesn’t quite have SAFEs

Here’s the catch that trips up a lot of first-time founders: a SAFE is a US contract built around US company law and US tax treatment. It is not a recognised instrument under UK company law, and importing a Y Combinator-style SAFE wholesale into a UK company can create real problems, particularly around HMRC’s SEIS and EIS reliefs, which many UK angel investors rely on. Those reliefs generally require investors to hold actual shares (or a qualifying right to shares) that meet specific conditions, and a badly drafted SAFE can fall outside that qualifying treatment, or create uncertainty that makes cautious investors walk away.

The UK equivalent: the advance subscription agreement

What UK startups actually use, when they want the SAFE-style speed, is an advance subscription agreement (ASA), sometimes marketed under SAFE-like branding by legal tech providers. An ASA works on a broadly similar principle: an investor advances money now in return for shares to be issued at a future date, typically triggered by the next qualifying funding round. The key differences from a true US SAFE are usually:

• A long-stop date, a maximum period (often measured in months) after which, if no priced round has happened, shares must be issued anyway, often at a pre-agreed valuation cap or a fixed price. HMRC guidance on SEIS and EIS generally expects conversion within a reasonably short window, not an open-ended one, so ASAs used for tax-advantaged investment need this discipline built in.
• No repayment right in most cases, so the money is genuinely at risk, which is part of what keeps it inside SEIS/EIS qualifying rules.
• UK share law mechanics: because shares can only be issued following proper board and shareholder approval, an ASA needs company law formalities (board minutes, resolutions, filings at Companies House) that a purely contractual US SAFE glosses over.

How a priced equity round works

A priced round is the more traditional route: founders and investors negotiate a valuation for the company today, agree how many shares that buys, and the investor becomes a shareholder immediately on completion. This involves a shareholders’ agreement, updated articles of association, share subscription documents, and usually more legal cost and negotiation time than a SAFE or ASA. In return, everyone knows exactly what they own, from day one, and rights like board seats, information rights, anti-dilution protection and liquidation preference can be negotiated and locked in immediately rather than left to be sorted out later.

The core trade-offs

• Speed and cost: SAFEs and ASAs are quicker and cheaper to paper than a priced round, which suits small pre-seed cheques where a full legal process would eat a disproportionate amount of the money raised.
• Valuation certainty: a priced round fixes dilution now; a SAFE/ASA defers the valuation conversation to the next round, using a valuation cap and/or discount to reward early investors for taking risk sooner. Founders need to model carefully how multiple SAFEs or ASAs, stacked with different caps, will dilute them when they finally convert, because the effect can be larger and messier than it first appears.
• Investor rights: priced-round investors typically get governance rights (board observer or director seats, veto rights over certain decisions) that SAFE/ASA holders usually don’t have until conversion.
• Tax relief mechanics: SEIS and EIS are a major reason UK seed investors invest at all, and eligibility depends on the precise legal form of the instrument and the timing of the share issue, not just its label. A UK-specific ASA drafted with SEIS/EIS in mind, and reviewed against current HMRC guidance, is a very different thing from a copy-pasted US SAFE template.
• Company law formality: UK share issuance always requires Companies House filings and Companies Act-compliant board and shareholder approvals, whatever the underlying commercial agreement says.

What founders should actually check

Before using either instrument, founders should get UK-qualified legal advice rather than assuming a US template will translate directly. Confirm with an accountant or tax adviser whether the investment is intended to be SEIS or EIS qualifying, and check the current conditions and limits directly with HMRC’s guidance, since thresholds and rules are updated periodically and are not something to rely on from memory or old blog posts. Model out fully diluted ownership under a range of future valuation scenarios before agreeing a cap or discount, and keep records of every conversion right stacked up across multiple early cheques, since it is very easy to lose track of how much of the company has effectively already been promised away by the time the first priced round happens.

Used well, both instruments are useful tools rather than rivals: many UK companies raise a pre-seed or seed amount on ASAs, then do a fully priced round once there is enough traction to negotiate a valuation properly. The mistake to avoid is treating a US SAFE as if it were a UK legal document, or treating an ASA as risk-free just because it looks simple on the page.